Cardiomyopathy in Africa: Heredity versus environment

Cardiovascular Journal of South Africa

Volumn 18, Issue 3, 2007, Pages 175-179

  Mayosi, Bongani M ^a   Somers, Krishna ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CARDIOMYOPATHY; CLIMATE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EOSINOPHILIA; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; GEOGRAPHIC DISTRIBUTION; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTROPHIC CARDIOMYOPATHY; PATHOGENESIS; PREVALENCE; REVIEW; SOCIOECONOMICS; SURVIVAL RATE; DEMOGRAPHY; ENDEMIC DISEASE; GENETIC HETEROGENEITY; INFLAMMATION; INHERITANCE; SURVIVAL; TROPICS;

AFRICA; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; ENDOMYOCARDIAL FIBROSIS; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HUMANS;

EID: 34548366492     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Omram AR. The epidemiological transition: a theory of the epidemiology of population change. Milbank Mem Fund Quart 1971; 49: 509-538.
2. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative disease. Milbank Mem Fund Quart 1986; 64: 355-391.
3. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
4. Mayosi BM, Avery PJ, Baker M, et al. Genotype at the -174G/C polymorphism of the tnterleukin-6 gene is associated with common carotid artery intimal-medial thickness. Family study and meta-analysis. Stroke 2005; 36: 2215-2219.
5. Mayosi BM, Keavney B, Watkins H, Farrall M. Measured haplotype analysis of the aldosterone synthase gene and heart size. Eur J Hum Genet 2003; 11: 395-401.
6. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005; 112: 3577-3583.
7. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005; 112: 3608-3616.
8. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
9. Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA. Molecular genetics of cardiomyopathy: changing times, shifting paradigms. Cardiovasc J South Afr 2003; 14: 145-155.
10. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Ann Rev Genom Hum Genet 2005; 6: 185-216.
11. Owor R, Rwomushana RJW. Familial congestive cardiomyopathy in Uganda. East Afr Med J 1975; 52: 372-375.
12. Brink AJ, Torrington M, van der Walt JJ. Hereditary dysrhythmic congestive cardiomyopathy. S Afr Med J 1976; 50: 2119-2123.
13. Przybojewski JZ, van der Walt JJ, van Eeden PJ, Tiedt FA. Familial dilated (congestive) cardiomyopathy. Occurrence in two brothers and an overview of the literature. S Afr Med J 1984; 66: 26-30.
14. Brink AJ, Torrington M. Progressive familial heart block - two types. S Afr Med J 1977; 52: 53-59.
15. Fernandez P, Moolman-Smook J, Brink P, Corfield V. A gene locus for progressive familial heart block type II (PFHBII) maps to chromosome 1q32.2-q32.3. Hum Genet 2005; 118: 1-5.
16. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82.
17. Maharaj B, Hammond MG. HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 65: 1402-1403.
18. Khogali SS, Mayosi BM, Beattie JM, McKenna WJ, Watkins H, Poulton J. A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations. Lancet 2001; 357: 1265-1267.
19. Mayosi BM, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 1999; 36: 796-797.
20. Mayosi BM, Meissenheimer L, Matolweni LO, Lawrenson J, Moolman-Smook JC. A cardiac troponin T gene mutation causes early-onset familial dilated cardiomyopathy in a South African family. Cardiovasc J South Afr 2004; 15: 237 (Abstract).
21. Magula NP, Mayosi BM. Cardiac involvement in HIV-infected people living in Africa: a review. Cardiovasc J South Afr 2003; 14: 231-237.
22. Cohen IS, Anderson DW, Virmani R, et al. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med 1986; 315: 628-620.
23. Longo-Mbenza B, Seghers LV, Vita EK, Tonduangu K, Bayekula M. Assessment of ventricular diastolic function in AIDS patients from Congo: a Doppler echocardiographic study. Heart 1998; 80: 184-189.
24. Williams AW. Heart disease in the native population of Uganda. East Afr Med J 1938; 15: 229.
25. Ball JD, Williams AW, Davies JNP. Endomyocardial fibrosis. Lancet 1954; 1: 1049.
26. Connor DH, Somers K, Hutt MS, Manion WC, D'Arbela PG. Endomyocardial fibrosis in Uganda (Davies' disease). 1. An epidemiologic, clinical, and pathologic study. Am Heart J 1967; 74: 687-709.
27. Connor DH, Somers K, Hutt MS, Manion WC, D'Arbela PG. Endomyocardial fibrosis in Uganda (Davies' disease). II. An epidemiologic, clinical, and pathologic study. Am Heart J 1968; 75: 107-124.
28. Davies JNP. Endomyocardial fibrosis: a heart disease of obscure aetiology in Africans. East Afr Med J 1948; 25: 10-16.
29. Freers J, Mayanja-Kizza H, Ziegler JL, Rutakingirwa M. Echocardiographic diagnosis of heart disease in Uganda. Trop Doct 1996; 26: 125-128.
30. Freers J, Hakim J, Myanja-Kizza H, Parry E. The heart. In: Parry E, Godfrey R, Mabey D, Gill G, eds. Principles of Medicine in Africa. 3rd edn. Cambridge, UK: Cambridge University Press, 2004: 837-886.
31. Freers J, Masembe V, Schmauz R, Mayanja-Kizza H. Endomyocardial fibrosis syndrome in Uganda. Lancet 2000; 355: 1994-1995.
32. D'Arbela PG, Mutazindwa T, Patel AK, Somers K. Survival after first presentation with endomyocardial fibrosis. Br Heart J 1972; 34: 403.
33. Rutakingirwa M, Ziegler JL, Newton R, Freers J. Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Hlth 1999; 4: 229-235.
34. Brockington IF, Olsen EGJ, Goodwin JF. Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet 1967; i: 583.
35. Beck W. Cardiomyopathies in South Africa - a brief survey of the problem and current therapeutic approaches. Postgrad Med J 1978; 54: 469-474.
36. Adi FC. Endomyocardial fibrosis in two brothers. Br Heart J 1963; 25: 684.
37. Patel AK, Ziegler JL, D'Arbela PG, Somers K. Familial cases of endomyocardial fibrosis in Uganda. Br Med J 1971; 48: 331-334.
38. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, Esin RA. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 1998; 69: 127-140.
39. Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987; 1: 643-647.
40. Van der Geld H, Peetoom F, Somers K, Kanyerezi BR. Immunological and serological studies in endomyocardial fibrosis. Lancet 1966; ii: 1210-1214.
41. Kaprio J. Science, medicine, and the future: Genetic epidemiology. Br Med J 2000; 320: 1257-1259.
42. Mayosi BM, Watkins H. Impact of molecular genetics on clinical cardiology. J R Coll Phys Lond 1999; 33: 124-131.
43. Moolman-Smook JC, De Lange WJ, Bruwer EC, Brink PA, Corfield VA. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet 1999; 65: 1308-1320.
44. Munclinger MJ, Patel JJ, Mitha AS. Follow-up of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia. S Afr Med J 2000; 90: 61-68.
45. Dalla Volta S, Battaglia G, Zerbini E. 'Auricularization' on the right ventricular pressure curve. Am Heart J 1961; 61: 25-33.